Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lora S. Kirigin
Re-Ablation I-131 Activity Does Not Predict Treatment Success in Low- And Intermediate-Risk Patients With Differentiated Thyroid Carcinoma
Endocrine
Related publications
Post-Surgical Thyroid Ablation With Low or High Radioiodine Activities Results in Similar Outcomes in Intermediate Risk Differentiated Thyroid Cancer Patients
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Prescribed Activity of 131 I Therapy in Differentiated Thyroid Cancer
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Management of Low-Risk Patients With Thyroid Carcinoma and Detectable Thyroglobulin on T4 After Thyroidectomy and Ablation With Iodine-131
Arquivos Brasileiros de Endocrinologia & Metabologia
Radioactive Iodine Ablation May Not Decrease the Risk of Recurrence in Intermediate-Risk Papillary Thyroid Carcinoma
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Differentiated Thyroid Cancer in Pediatric Population (≤18 Years): Postoperative Treatment With Radioactive Iodine (I-131)
Acta Clinica Croatica
Medicine
Iodine 131 Treatment for Differentiated Thyroid Carcinoma in Patients With End Stage Renal Failure: Dosimetric, Radiation Safety, and Practical Considerations
Hormones
Medicine
Endocrinology
Metabolism
Diabetes
Usefulness of Dynamic Risk Stratification in Pediatric Patients With Differentiated Thyroid Carcinoma
Annals of Surgical Treatment and Research
Surgery
Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
Frontiers in Oncology
Cancer Research
Oncology
Lung Uptake on I-131 Therapy and Short-Term Outcome in Patients With Lung Metastasis From Differentiated Thyroid Cancer
Annals of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
